Jennifer Champoux

Vermögen: 809 999 $ am 31.05.2024

Health Technology

Consumer Services

Aktive Positionen von Jennifer Champoux

Unternehmen	Position	Beginn	Ende
MONTE ROSA THERAPEUTICS, INC.	Geschäftsführer	01.03.2021	-
MONTE ROSA THERAPEUTICS, INC.	Personalreferent	01.03.2021	28.05.2024

Unternehmen	Position	Beginn	Ende
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Corporate Officer/Principal	-	-

Indiana University

Graduate Degree

International

Vereinigte Staaten

Operativ

Chief Operating Officer	1
Human Resources Officer	1
Corporate Officer/Principal	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
MONTE ROSA THERAPEUTICS, INC.	Health Technology

Private Unternehmen	1
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Health Technology

Private Unternehmen

Health Technology